Salvatore Piscuoglio is an Associate Professor of Genetics at the Humanitas University and a Group Leader at the Humanitas Research Hospital, where he leads the Precision Medicine Research Lab.

He obtained his degree in Medical Biotechnology from the University of Naples “Federico II” in 2008 and his PhD in Genetics from the University of Basel, Switzerland, in 2012. After completing his studies, he joined the Memorial Sloan-Kettering Cancer Center in New York, USA, as a postdoctoral researcher in 2013. There, he worked on characterizing human cancers using omics technologies to discover new biomarkers and therapeutic targets, and to elucidate genotype-to-phenotype associations.

Upon completing his postdoctoral training in 2016, Salvatore became a Group Leader at the Institute of Medical Genetics and Pathology at the University Hospital Basel. In 2019, he also became a Group Leader at the Department of Biomedicine, University of Basel, and the co-director of research at the Institute of Medical Genetics and Pathology at the University Hospital Basel. He joined Humanitas as an Associate Professor and Group Leader in 2024.

Salvatore’s research focuses on defining novel cancer genes, identifying clinically relevant predictive biomarkers of response or resistance to therapy, and discovering new drug targets. He uses a multi-modality approach that incorporates computational predictions, multi-omics profiling, and ex-vivo drug profiling.